[ad_1]
Hugo Boss shares fell sharply on Tuesday after the suit seller followed rivals Burberry and Swatch Group in cutting its guidance over concerns that a slump in the global economy is set to hit sales in key markets including the U.K. and China throughout the remainder of 2024.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...